Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daichi Fujimoto

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
JAMA Network Open|February 24, 2023
Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial EligibilityDaichi Fujimoto, Takeshi Morimoto, Motohiro Tamiya, et al.
Clinical Lung Cancer|January 3, 2026
Multicenter Real-World Data on First-Line Chemoimmunotherapy in Patients With Advanced Non-Small Cell Lung Cancer and Performance Status 2: WJOG18424LShunichi Kataoka, Takehito Shukuya, Hiroshi Ohtsu, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2024
Prediction of prognosis in lung cancer using machine learning with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND)Daichi Fujimoto, Hidetoshi Hayashi, Kenta Murotani, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 5, 2024
Impact of morphofunctional assessment with quantitative flow ratio and optical coherence tomography in patients with acute coronary syndromesYuto Osumi, Hiroyuki Kawamori, Takayoshi Toba, et al.
ESMO Open|July 22, 2020
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR)Kyoichi Okishio, Ryo Morita, Junichi Shimizu, et al.
Journal of the American Heart Association|March 10, 2026
Impact of Perivascular Adipose Tissue Attenuation Around the Aortic Valve on Clinical Outcomes After Transcatheter Aortic Valve ReplacementHiroya Okamoto, Takayoshi Toba, Yoichiro Sugizaki, et al.
Lung Cancer (Amsterdam, Netherlands)|December 16, 2019
Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in JapanRyo Morita, Kyoichi Okishio, Junichi Shimizu, et al.
Scientific Reports|March 6, 2023
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancerDaichi Fujimoto, Satoru Miura, Keisuke Tomii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2024
YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant CancersYuki Katayama, Tadaaki Yamada, Keiko Tanimura, et al.
American Journal of Respiratory and Critical Care Medicine|July 3, 2026
Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trialDaichi Fujimoto, Mitsuhiro Abe, Kenta Murotani, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
JAMA Network Open|February 24, 2023
Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial EligibilityDaichi Fujimoto, Takeshi Morimoto, Motohiro Tamiya, et al.
Clinical Lung Cancer|January 3, 2026
Multicenter Real-World Data on First-Line Chemoimmunotherapy in Patients With Advanced Non-Small Cell Lung Cancer and Performance Status 2: WJOG18424LShunichi Kataoka, Takehito Shukuya, Hiroshi Ohtsu, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2024
Prediction of prognosis in lung cancer using machine learning with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND)Daichi Fujimoto, Hidetoshi Hayashi, Kenta Murotani, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 5, 2024
Impact of morphofunctional assessment with quantitative flow ratio and optical coherence tomography in patients with acute coronary syndromesYuto Osumi, Hiroyuki Kawamori, Takayoshi Toba, et al.
ESMO Open|July 22, 2020
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR)Kyoichi Okishio, Ryo Morita, Junichi Shimizu, et al.
Journal of the American Heart Association|March 10, 2026
Impact of Perivascular Adipose Tissue Attenuation Around the Aortic Valve on Clinical Outcomes After Transcatheter Aortic Valve ReplacementHiroya Okamoto, Takayoshi Toba, Yoichiro Sugizaki, et al.
Lung Cancer (Amsterdam, Netherlands)|December 16, 2019
Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in JapanRyo Morita, Kyoichi Okishio, Junichi Shimizu, et al.
Scientific Reports|March 6, 2023
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancerDaichi Fujimoto, Satoru Miura, Keisuke Tomii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2024
YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant CancersYuki Katayama, Tadaaki Yamada, Keiko Tanimura, et al.
American Journal of Respiratory and Critical Care Medicine|July 3, 2026
Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trialDaichi Fujimoto, Mitsuhiro Abe, Kenta Murotani, et al.
Pageof 17